EDESA BIOTECH, INC. Proceeds from Issuance of Warrants
EDESA BIOTECH, INC. (EDSA) reported Proceeds from Issuance of Warrants of $3.86 million for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2023-08-09
- 2023-06-30: Proceeds from Issuance of Warrants 9 month $3.86M.
- 2022-06-30: Proceeds from Issuance of Warrants 9 month $11.96M.
- 2018-05-24: Proceeds from Issuance of Warrants 1 month $2.50M.
| Period end | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 9 month |
|---|---|---|
| 2023-06-30 | $3.86M 10-Q · filed 2023-08-09 | |
| 2022-06-30 | $11.96M 10-Q · filed 2023-08-09 | |
| 2018-05-24 | $2.50M 10-K · filed 2018-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |